At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
EPIONE devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Clinical Investigation on the Evaluation of Performance and Safety of the EPIONE Assisted CT-guided Percutaneous Procedures in the Lungs
In Brief
A clinical study evaluating EPIONE device for Lung Cancer. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for percutaneous procedures in the lung.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
First PostedDec 2022
Primary CompletionAug 2023
Study CompletionSep 2024
TodayJul 2026
First PostedDec 15, 2022
Enrollment StartNov 28, 2022
Primary CompletionAug 25, 2023
Study CompletionSep 10, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.5 years ago
Interventions
EPIONE devicedevice
The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures.